Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Duration of travel-associated faecal colonisation with ESBL-producing Enterobacteriaceae - A one year follow-up study.

ÖstholmBalkhed Å, Tärnberg M, Nilsson M, Nilsson LE, Hanberger H, Hällgren A; Southeast Sweden Travel Study Group.

PLoS One. 2018 Oct 24;13(10):e0205504. doi: 10.1371/journal.pone.0205504. eCollection 2018.

2.

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia.

Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, Kollef M, Li Bassi G, Luna CM, Martin-Loeches I, Paiva JA, Read RC, Rigau D, François Timsit J, Welte T, Wunderink R.

ERJ Open Res. 2018 Jun 26;4(2). pii: 00028-2018. doi: 10.1183/23120541.00028-2018. eCollection 2018 Apr.

3.

Ventilator-associated respiratory infection in a resource-restricted setting: impact and etiology.

Phu VD, Nadjm B, Duy NHA, Co DX, Mai NTH, Trinh DT, Campbell J, Khiem DP, Quang TN, Loan HT, Binh HS, Dinh QD, Thuy DB, Lan HNP, Ha NH, Bonell A, Larsson M, Hoan HM, Tuan ĐQ, Hanberger H, Minh HNV, Yen LM, Van Hao N, Binh NG, Chau NVV, Van Kinh N, Thwaites GE, Wertheim HF, van Doorn HR, Thwaites CL.

J Intensive Care. 2017 Dec 19;5:69. doi: 10.1186/s40560-017-0266-4. eCollection 2017.

4.

Colistin- and carbapenem-resistant Klebsiella pneumoniae carrying mcr-1 and blaOXA-48 isolated at a paediatric hospital in Vietnam.

Berglund B, Hoang NTB, Tärnberg M, Le NK, Welander J, Nilsson M, Khu DTK, Nilsson LE, Olson L, Le HT, Larsson M, Hanberger H.

J Antimicrob Chemother. 2018 Apr 1;73(4):1100-1102. doi: 10.1093/jac/dkx491. No abstract available.

PMID:
29253209
5.

Insertion sequence transpositions and point mutations in mgrB causing colistin resistance in a clinical strain of carbapenem-resistant Klebsiella pneumoniae from Vietnam.

Berglund B, Hoang NTB, Tärnberg M, Le NK, Svartström O, Khu DTK, Nilsson M, Le HT, Welander J, Olson L, Larsson M, Nilsson LE, Hanberger H.

Int J Antimicrob Agents. 2018 May;51(5):789-793. doi: 10.1016/j.ijantimicag.2017.11.012. Epub 2017 Nov 24.

PMID:
29180281
6.

Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance.

Mölstad S, Löfmark S, Carlin K, Erntell M, Aspevall O, Blad L, Hanberger H, Hedin K, Hellman J, Norman C, Skoog G, Stålsby-Lundborg C, Tegmark Wisell K, Åhrén C, Cars O.

Bull World Health Organ. 2017 Nov 1;95(11):764-773. doi: 10.2471/BLT.16.184374. Epub 2017 Oct 3.

7.
8.

14-Year Survey in a Swedish County Reveals a Pronounced Increase in Bloodstream Infections (BSI). Comorbidity - An Independent Risk Factor for Both BSI and Mortality.

Holmbom M, Giske CG, Fredrikson M, Östholm Balkhed Å, Claesson C, Nilsson LE, Hoffmann M, Hanberger H.

PLoS One. 2016 Nov 11;11(11):e0166527. doi: 10.1371/journal.pone.0166527. eCollection 2016.

9.

High prevalence of hospital-acquired infections caused by gram-negative carbapenem resistant strains in Vietnamese pediatric ICUs: A multi-centre point prevalence survey.

Le NK, Hf W, Vu PD, Khu DT, Le HT, Hoang BT, Vo VT, Lam YM, Vu DT, Nguyen TH, Thai TQ, Nilsson LE, Rydell U, Nguyen KV, Nadjm B, Clarkson L, Hanberger H, Larsson M.

Medicine (Baltimore). 2016 Jul;95(27):e4099. doi: 10.1097/MD.0000000000004099.

10.

Repeated nationwide point-prevalence surveys of antimicrobial use in Swedish hospitals: data for actions 2003-2010.

Skoog G, Struwe J, Cars O, Hanberger H, Odenholt I, Prag M, Skärlund K, Ulleryd P, Erntell M.

Euro Surveill. 2016 Jun 23;21(25). doi: 10.2807/1560-7917.ES.2016.21.25.30264.

11.

Surveillance of antibiotic susceptibility in a Swedish Burn Center 1994-2012.

Fransén J, Huss FR, Nilsson LE, Rydell U, Sjöberg F, Hanberger H.

Burns. 2016 Sep;42(6):1295-303. doi: 10.1016/j.burns.2016.01.025. Epub 2016 May 27.

PMID:
27241732
12.

Key priorities in the prevention and control of healthcare-associated infection: a survey of European and other international infection prevention experts.

Dettenkofer M, Humphreys H, Saenz H, Carlet J, Hanberger H, Ruef C, Widmer A, Wolkewitz M, Cookson B.

Infection. 2016 Dec;44(6):719-724. Epub 2016 May 25.

PMID:
27225779
13.

High Prevalence of Heterogeneously Glycopeptide-Intermediate Coagulase-Negative Staphylococci in Sternal Wounds.

Berglund B, Claesson C, Nilsson LE, Hanberger H.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):5097-8. doi: 10.1128/AAC.00217-16. Print 2016 Aug. No abstract available.

14.

Nya rekommendationer vid sjukhusförvärvad pneumoni - Starta smart - sedan fokusera, enligt Läkemedelsverkets expertmöte.

Hanberger H, Claesson K.

Lakartidningen. 2016 Feb 26;113. pii: DW77. Swedish. No abstract available.

15.

Burden of Hospital Acquired Infections and Antimicrobial Use in Vietnamese Adult Intensive Care Units.

Phu VD, Wertheim HF, Larsson M, Nadjm B, Dinh QD, Nilsson LE, Rydell U, Le TT, Trinh SH, Pham HM, Tran CT, Doan HT, Tran NT, Le ND, Huynh NV, Tran TP, Tran BD, Nguyen ST, Pham TT, Dang TQ, Nguyen CV, Lam YM, Thwaites G, Van Nguyen K, Hanberger H.

PLoS One. 2016 Jan 29;11(1):e0147544. doi: 10.1371/journal.pone.0147544. eCollection 2016.

16.

[Sepsis--the unknown public disease of our time].

Mellhammar L, Kander T, Christensson B, Herwald H, Egesten A, Larsson A, Sjölin J, Brink M, Mehle C, Hanberger H, Gårdlund B, Oldner A, Källman J, Linder A.

Lakartidningen. 2015 Nov 17;112. pii: DSAI. Swedish. No abstract available.

17.
18.

[Response times can be shortened in microbiological diagnosis of sepsis. Better opening hours in laboratories and active advice enables faster therapy].

Åkerlund A, Sundqvist M, Hanberger H, Åhrén C, Serrander L, Giske CG.

Lakartidningen. 2015 Feb 10;112. pii: C73S. Swedish.

19.

Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels.

Hanberger H, Antonelli M, Holmbom M, Lipman J, Pickkers P, Leone M, Rello J, Sakr Y, Walther SM, Vanhems P, Vincent JL; EPIC II Group of Investigators.

BMC Infect Dis. 2014 Sep 22;14:513. doi: 10.1186/1471-2334-14-513.

20.

[New antibiotics with activity against multidrug-resistant enterobacteriaceae. Combination preparations are now being tested clinically].

Petropoulos EA, Hanberger H, Giske CG.

Lakartidningen. 2014 Jun 11-17;111(24):1050-1. Swedish. No abstract available.

21.

[Botulism is a treatable, very rare type of poisoning. Smoked vacuum packed whitefish provided guidance to the diagnosis].

Lundin F, Personne M, Hanberger H.

Lakartidningen. 2014 Mar 19-Apr 1;111(12-13):551-2. Swedish. No abstract available.

PMID:
24734378
22.

Antibiotic consumption and antibiotic stewardship in Swedish hospitals.

Hanberger H, Skoog G, Ternhag A, Giske CG.

Ups J Med Sci. 2014 May;119(2):154-61. doi: 10.3109/03009734.2014.909911. Epub 2014 Apr 11. Review.

23.

[Aminoglycosides are effective--but oto- and nephrotoxic. Knowledge base from the reference group for antibiotic issues on benefit-risk with aminoglycosides].

Ternhag A, Giske CG, Hanberger H.

Lakartidningen. 2014 Feb 12-18;111(7):268-9. Swedish. No abstract available.

PMID:
24669487
24.

Sustained low incidence of central venous catheter-related infections over six years in a Swedish hospital with an active central venous catheter team.

Hammarskjöld F, Berg S, Hanberger H, Taxbro K, Malmvall BE.

Am J Infect Control. 2014 Feb;42(2):122-8. doi: 10.1016/j.ajic.2013.09.023.

PMID:
24485369
25.

Late-onset neonatal sepsis, risk factors and interventions: an analysis of recurrent outbreaks of Serratia marcescens, 2006-2011.

Samuelsson A, Isaksson B, Hanberger H, Olhager E.

J Hosp Infect. 2014 Jan;86(1):57-63. doi: 10.1016/j.jhin.2013.09.017. Epub 2013 Oct 23.

PMID:
24332914
26.

Possible transmission of Candida albicans on an intensive care unit: genotype and temporal cluster analyses.

Hammarskjöld F, Mernelius S, Andersson RE, Berg S, Hanberger H, Löfgren S, Malmvall BE, Petzold M, Matussek A.

J Hosp Infect. 2013 Sep;85(1):60-5. doi: 10.1016/j.jhin.2013.06.002. Epub 2013 Aug 5.

PMID:
23927923
27.

Rational use of aminoglycosides - author response.

Hanberger H, Fredriksson M, Ternhag A, Giske CG.

Scand J Infect Dis. 2013 Aug;45(8):655-6. doi: 10.3109/00365548.2013.793820. Epub 2013 May 22. No abstract available.

PMID:
23692443
28.

Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors.

Ostholm-Balkhed A, Tärnberg M, Nilsson M, Nilsson LE, Hanberger H, Hällgren A; Travel Study Group of Southeast Sweden.

J Antimicrob Chemother. 2013 Sep;68(9):2144-53. doi: 10.1093/jac/dkt167. Epub 2013 May 14.

29.

Providing impetus, tools, and guidance to strengthen national capacity for antimicrobial stewardship in Viet Nam.

Wertheim HF, Chandna A, Vu PD, Pham CV, Nguyen PD, Lam YM, Nguyen CV, Larsson M, Rydell U, Nilsson LE, Farrar J, Nguyen KV, Hanberger H.

PLoS Med. 2013;10(5):e1001429. doi: 10.1371/journal.pmed.1001429. Epub 2013 May 7. No abstract available.

30.

A prospective observational study on 249 subcutaneous central vein access ports in a Swedish county hospital.

Taxbro K, Berg S, Hammarskjöld F, Hanberger H, Malmvall BE.

Acta Oncol. 2013 Jun;52(5):893-901. doi: 10.3109/0284186X.2013.770601. Epub 2013 Feb 22.

PMID:
23432403
31.

Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).

Hanberger H, Edlund C, Furebring M, G Giske C, Melhus A, Nilsson LE, Petersson J, Sjölin J, Ternhag A, Werner M, Eliasson E; Swedish Reference Group for Antibiotics.

Scand J Infect Dis. 2013 Mar;45(3):161-75. doi: 10.3109/00365548.2012.747694. Epub 2012 Dec 28. Review.

PMID:
23270477
32.

Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection.

Ammerlaan HS, Harbarth S, Buiting AG, Crook DW, Fitzpatrick F, Hanberger H, Herwaldt LA, van Keulen PH, Kluytmans JA, Kola A, Kuchenbecker RS, Lingaas E, Meessen N, Morris-Downes MM, Pottinger JM, Rohner P, dos Santos RP, Seifert H, Wisplinghoff H, Ziesing S, Walker AS, Bonten MJ.

Clin Infect Dis. 2013 Mar;56(6):798-805. doi: 10.1093/cid/cis1006. Epub 2012 Dec 7.

33.

High frequency of co-resistance in CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden.

Östholm Balkhed Å, Tärnberg M, Monstein HJ, Hällgren A, Hanberger H, Nilsson LE.

Scand J Infect Dis. 2013 Apr;45(4):271-8. doi: 10.3109/00365548.2012.734636. Epub 2012 Oct 31.

PMID:
23113731
34.

Changes in the aerobic faecal flora of patients treated with antibiotics for acute intra-abdominal infection.

Samuelsson A, Isaksson B, Chabok A, Jonasson J, Nilsson LE, Eriksson O, Hanberger H.

Scand J Infect Dis. 2012 Nov;44(11):820-7. doi: 10.3109/00365548.2012.695455. Epub 2012 Jul 25.

PMID:
22831634
35.

When and how to cover for resistant gram-negative bacilli in severe sepsis and septic shock.

Hanberger H, Giske CG, Giamarellou H.

Curr Infect Dis Rep. 2011 Oct;13(5):416-25. doi: 10.1007/s11908-011-0200-1.

PMID:
21800232
36.

Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study.

Hanberger H, Walther S, Leone M, Barie PS, Rello J, Lipman J, Marshall JC, Anzueto A, Sakr Y, Pickkers P, Felleiter P, Engoren M, Vincent JL; EPIC II Group of Investigators.

Int J Antimicrob Agents. 2011 Oct;38(4):331-5. doi: 10.1016/j.ijantimicag.2011.05.013. Epub 2011 Jul 28.

PMID:
21798720
37.

Need for improved antimicrobial and infection control stewardship in Vietnamese intensive care units.

Johansson M, Phuong DM, Walther SM, Hanberger H.

Trop Med Int Health. 2011 Jun;16(6):737-43. doi: 10.1111/j.1365-3156.2011.02753.x. Epub 2011 Mar 16.

38.

In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli.

Tärnberg M, Ostholm-Balkhed A, Monstein HJ, Hällgren A, Hanberger H, Nilsson LE.

Eur J Clin Microbiol Infect Dis. 2011 Aug;30(8):981-7. doi: 10.1007/s10096-011-1183-4. Epub 2011 Feb 6.

PMID:
21298459
39.

Low incidence of arterial catheter infections in a Swedish intensive care unit: risk factors for colonisation and infection.

Hammarskjöld F, Berg S, Hanberger H, Malmvall BE.

J Hosp Infect. 2010 Oct;76(2):130-4. doi: 10.1016/j.jhin.2010.05.021. Epub 2010 Aug 9.

PMID:
20692072
40.

Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae and trends in antibiotic consumption in a county of Sweden.

Ostholm-Balkhed A, Tärnberg M, Nilsson M, Johansson AV, Hanberger H, Monstein HJ, Nilsson LE.

Scand J Infect Dis. 2010 Dec;42(11-12):831-8. doi: 10.3109/00365548.2010.498017. Epub 2010 Jul 7.

PMID:
20608768
41.

Prevalence of fecal carriage of antibiotic-resistant bacteria in patients with acute surgical abdominal infections.

Chabok A, Tärnberg M, Smedh K, Påhlman L, Nilsson LE, Lindberg C, Hanberger H.

Scand J Gastroenterol. 2010 Oct;45(10):1203-10. doi: 10.3109/00365521.2010.495417.

PMID:
20521871
42.

Implementation of selective digestive decontamination in the intensive care unit: a word of caution.

Walther S, Gill H, Hanberger H; Swedish Intensive Care Registry (SIR); Swedish strategic programme against antibiotic resistance in critical care (SIR-IVAStrama).

Acta Anaesthesiol Scand. 2010 Apr;54(4):526-7. doi: 10.1111/j.1399-6576.2009.02198.x. No abstract available.

PMID:
20415952
43.

[The "push" and "pull" method to reduce nosocomial infections at ICU. A pilot project with an active follow up].

Agvald-Ohman C, Hanberger H, Struwe J, Walther SM.

Lakartidningen. 2010 Jan 13-19;107(1-2):28-31. Swedish. No abstract available.

PMID:
20184269
44.

[Strama suggests a national goal: Halved antibiotics prescriptions in metropolitan areas in five years].

André M, Blad L, Dohnhammar U, Erntell M, Hanberger H, Isaksson B, Melander E, Mölstad S, Norman C, Lundborg CS, Ulleryd P, Wahlberg K; Strama; Strategigruppen för rationell antibiotikaanvändning och minskad antibiotikaresistens.

Lakartidningen. 2009 Nov 18-24;106(47):3133-4. Swedish. No abstract available.

PMID:
20077636
45.

[Time to abandon "the house wine". Stop for uncritical empiric use of cefuroxime].

Hanberger H, Odenholt I, Giske CG, Kahlmeter G.

Lakartidningen. 2009 Jan 28-Feb 3;106(5):291-2. Swedish. No abstract available.

PMID:
19271459
46.

Molecular detection of aggregation substance, enterococcal surface protein, and cytolysin genes and in vitro adhesion to urinary catheters of Enterococcus faecalis and E. faecium of clinical origin.

Hällgren A, Claesson C, Saeedi B, Monstein HJ, Hanberger H, Nilsson LE.

Int J Med Microbiol. 2009 Jun;299(5):323-32. doi: 10.1016/j.ijmm.2008.10.001. Epub 2008 Nov 29.

PMID:
19042153
47.

Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control.

Hanberger H, Arman D, Gill H, Jindrák V, Kalenic S, Kurcz A, Licker M, Naaber P, Scicluna EA, Vanis V, Walther SM.

Intensive Care Med. 2009 Jan;35(1):91-100. doi: 10.1007/s00134-008-1237-y. Epub 2008 Aug 1.

PMID:
18670757
48.

Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs.

Erlandsson M, Gill H, Nordlinder D, Giske CG, Jonas D, Nilsson LE, Walther S, Hanberger H.

Scand J Infect Dis. 2008;40(6-7):487-94. doi: 10.1080/00365540701864641.

PMID:
18584536
49.

Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme.

Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, Lundborg CS, Söderström A, Torell E, Cars O.

Lancet Infect Dis. 2008 Feb;8(2):125-32. doi: 10.1016/S1473-3099(08)70017-3. Review.

PMID:
18222163
50.

[New Strama-work in Ostergotland. The LIRA-concept gives best results].

Hanberger H, Dannetun E, Rutberg H.

Lakartidningen. 2007 Nov 7-13;104(45):3351-2. Swedish. No abstract available.

PMID:
18062634

Supplemental Content

Loading ...
Support Center